Vitiligo. Treatment of 12 cases with topical tacrolimus;Vitíligo. Tratamiento de 12 casos con tacrolimus tópico

Actas Dermo-Sifiliograficas

Volumn 96, Issue 3, 2005, Pages 159-163

  Almeida, Pablo ^a   Borrego, Leopoldo ^a   Rodríguez López, Julio ^a   Luján, Dunia ^a   Cameselle, Daniel ^a   Hernández, Buenaventura ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Dyschromia; Hypopigmentation; Tacrolimus; Topical treatment; Vitiligo

Indexed keywords

TACROLIMUS;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG APPROVAL; EYELID DISEASE; FACE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; MELANOCYTE; PHOTOGRAPHY; PRURITUS; SIDE EFFECT; SKIN DISEASE; SKIN PIGMENTATION; STREPTOMYCES TSUKUBAENSIS; TREATMENT OUTCOME; VALIDATION PROCESS; VITILIGO;

EID: 18944388051     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(05)73058-1     Document Type: Article

References (13)

1. Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity. 2001;34:65-77.
2. Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatosis. JEADV. 2002;16: 100-14.
3. Khalid M, Multaba G, Tahir SH. Comparison of 0,05% clobetasol propionate cream and topical puvasol in childhood vitiligo. Int J Dermatol. 1995;34:203-5.
4. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol. 1998;134: 1532-40.
5. Falabella R. Surgical treatment of vitiligo: Why, When and How. JEADV. 2003;17:518-20.
6. Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology. 2002;205:301-3.
7. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0,1% tacrolimus ointment. Arch Dermatol. 2003;139:571-74.
8. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47: 789-91.
9. Lepe V, Moncada B, Castanedo JP. A double-blind randomized trial of 0,1% tacrolimus versus 0,05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003; 139:581-5.
10. Tanghetti EA. Tacrolimus ointment 0,1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis. 2003;71:158-62.
11. Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647-66.
12. Castanedo-Cazares JP, Lepe V, Moncada B. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band. Photodermatol Photoimmunol Photomed. 2003;19:35-6.
13. Niwa Y, Terashima T, Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol. 2003;149:960-7.